Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer.

Yinxing ZhuYixuan HuJunfeng ShiXiaowei WeiYaqi SongCuiju TangWenwen Zhang

Published in: Technology in cancer research & treatment (2023)

Collectively, all these results demonstrated plasma TrxR is an effective parameter for gynecologic cancer diagnosis and concurrently acts as a promising biomarker for treatment response assessment.

Keyphrases

papillary thyroid
squamous cell
endometrial cancer
squamous cell carcinoma
lymph node metastasis
young adults